119 related articles for article (PubMed ID: 38110724)
1. Decreased serum creatinine to cystatin C ratio is associated with low tongue pressure.
Komorita Y; Ide H; Yoshinari M; Ohta Y; Nakamichi I; Fujisawa R; Fujii W; Fukuhara M
Geriatr Gerontol Int; 2024 Jan; 24(1):102-108. PubMed ID: 38110724
[TBL] [Abstract][Full Text] [Related]
2. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
[TBL] [Abstract][Full Text] [Related]
3. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
[TBL] [Abstract][Full Text] [Related]
4. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease.
Kawasaki Y; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
Respir Investig; 2024 Jan; 62(1):143-149. PubMed ID: 38134662
[TBL] [Abstract][Full Text] [Related]
6. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
[TBL] [Abstract][Full Text] [Related]
7. Association between oral frailty and cystatin C-related indices-A questionnaire (OFI-8) study in general internal medicine practice.
Kusunoki H; Ekawa K; Kato N; Yamasaki K; Motone M; Shinmura K; Yoshihara F; Shimizu H
PLoS One; 2023; 18(4):e0283803. PubMed ID: 37093792
[TBL] [Abstract][Full Text] [Related]
8. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Huang D; Xie C; Sun C; Chen M; Li L; Yi H; Liao J; Zhao X; Shen X; He D; Li D; Wu D
Int J Chron Obstruct Pulmon Dis; 2022; 17():781-789. PubMed ID: 35422619
[TBL] [Abstract][Full Text] [Related]
9. Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer.
Fukushima R; Harimoto N; Okuyama T; Seki T; Hoshino K; Hagiwara K; Kawai S; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Shirabe K
Int J Clin Oncol; 2024 Jul; 29(7):1002-1011. PubMed ID: 38683456
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum creatinine/cystatin C ratio and mortality in hypertensive patients.
Liao L; Shi S; Ding B; Zhang R; Tu J; Zhao Y; Guo Q; Liao Y
Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):369-376. PubMed ID: 37949717
[TBL] [Abstract][Full Text] [Related]
11. Low serum creatinine to cystatin C ratio is independently associated with sarcopenia and high carotid plaque score in patients with type 2 diabetes.
Shin JY
Nutr Metab Cardiovasc Dis; 2022 Jun; 32(6):1454-1462. PubMed ID: 35256230
[TBL] [Abstract][Full Text] [Related]
12. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.
Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q
Front Nutr; 2022; 9():963265. PubMed ID: 36118766
[TBL] [Abstract][Full Text] [Related]
13. Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease.
Hyun YY; Lee KB; Kim H; Kim Y; Chung W; Park HC; Han SH; Oh YK; Park SK; Oh KH
Front Nutr; 2022; 9():996674. PubMed ID: 36225865
[TBL] [Abstract][Full Text] [Related]
14. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
[TBL] [Abstract][Full Text] [Related]
15. Serum Creatinine/Cystatin C Ratio Associated with Cross-Sectional Area of Erector Spinae Muscles and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease.
Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
Int J Chron Obstruct Pulmon Dis; 2021; 16():3513-3524. PubMed ID: 34992359
[TBL] [Abstract][Full Text] [Related]
16. Relationships between cystatin C and creatinine-based eGFR with low tongue pressure in Japanese rural community-dwelling older adults.
Kusunoki H; Hasegawa Y; Tsuji S; Wada Y; Tamaki K; Nagai K; Mori T; Matsuzawa R; Kishimoto H; Shimizu H; Shinmura K
Clin Exp Dent Res; 2022 Oct; 8(5):1259-1269. PubMed ID: 35749633
[TBL] [Abstract][Full Text] [Related]
17. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
[TBL] [Abstract][Full Text] [Related]
18. Serum creatinine/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults.
Tan L; Li R; Hu X; Zhu Y; Bao T; Zuo Y; Yang M
Sci Rep; 2020 Aug; 10(1):14028. PubMed ID: 32820230
[TBL] [Abstract][Full Text] [Related]
19. Estimation of Muscle Mass Using Creatinine/Cystatin C Ratio in Japanese Community-Dwelling Older People.
Kusunoki H; Tabara Y; Tsuji S; Wada Y; Tamaki K; Nagai K; Itoh M; Sano K; Amano M; Maeda H; Sugita H; Hasegawa Y; Kishimoto H; Shimomura S; Igase M; Shinmura K
J Am Med Dir Assoc; 2022 May; 23(5):902.e21-902.e31. PubMed ID: 34437868
[TBL] [Abstract][Full Text] [Related]
20. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
